Trisha Gura. Show Affiliations »
Abstract
Mesh: See more » Agouti-Related ProteinAnimalsAnti-Obesity Agents/adverse effectsAnti-Obesity Agents/pharmacologyAnti-Obesity Agents/therapeutic useAppetite/drug effectsArcuate Nucleus of Hypothalamus/metabolismCiliary Neurotrophic Factor/therapeutic useClinical Trials as TopicCyclobutanes/adverse effectsCyclobutanes/therapeutic useEnergy IntakeGhrelinHumansHunger/drug effectsIntercellular Signaling Peptides and ProteinsLactones/adverse effectsLactones/therapeutic useLeptin/metabolismLeptin/therapeutic useMiceNerve Tissue Proteins/adverse effectsNerve Tissue Proteins/therapeutic useNeurons/metabolismNeuropeptide Y/metabolismNeuropeptide Y/pharmacologyObesity/drug therapyObesity/metabolismOrlistatPeptide FragmentsPeptide Hormones/metabolismPeptide Hormones/pharmacologyPeptide YY/metabolismPeptide YY/pharmacologyPhentermine/adverse effectsPhentermine/therapeutic useProteins/metabolismReceptors, Corticotropin/metabolismReceptors, MelanocortinWeight Lossalpha-MSH/metabolism
Substances: See more » Agouti-Related ProteinAnti-Obesity AgentsCiliary Neurotrophic FactorCyclobutanesGhrelinIntercellular Signaling Peptides and ProteinsLactonesLeptinNerve Tissue ProteinsNeuropeptide YPeptide FragmentsPeptide HormonesProteinsReceptors, CorticotropinReceptors, MelanocortinPeptide YYpeptide YY (3-36)alpha-MSHOrlistataxokinePhenterminesibutramine
Year: 2003 PMID: 12574616 DOI: 10.1126/science.299.5608.849
Source DB: PubMed Journal: Science ISSN: 0036-8075 Impact factor: 47.728